Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia
Venetoclax is a powerful new kind of oral medication. It enables leukemia cells to die by interfering with Bcl-2, a […]
science
Companion Diagnostics? For Cancer Care, We Need Better Ones
These biomarkers should link patients to optimal therapy (when such exists), and lead some to decline therapy that’s unlikely to
Companion Diagnostics? For Cancer Care, We Need Better Ones Read More »
Precision Medicine Will (Eventually) Lower Cancer Care Costs
Over time, the costs should drop, like for smartphone tech, what my Dad – a chemistry major and retired physician
Precision Medicine Will (Eventually) Lower Cancer Care Costs Read More »
Can Journalists Be Too Skeptical About Progress Against Cancer?
On Twitter this week, I happened upon a discussion having to do with the possibility of curing cancer.
Can Journalists Be Too Skeptical About Progress Against Cancer? Read More »
How To Avoid Overdiagnosis And Overtreatment Of Breast Cancer
If overtreatment is the problem, the solution is not by avoidance of breast cancer detection, but by better education of
How To Avoid Overdiagnosis And Overtreatment Of Breast Cancer Read More »
Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
So far, the studies demonstrate that Lynparza has activity in cancer patients with and without inherited BRCA mutations.